It mediates several biological processes in cancer, such as cell proliferation, metastasis and drug resistance, via regulation of downstream signaling pathways, such as MEK/ERK and PI3K/AKT [17, 20, 41]. This evidence concerns the gene MAP2K7 and cancer.